We are thrilled to have been part of this major milestone for our portfolio company Genomcore ?? ?? Genomcore has successfully closed the largest funding round in its history; a remarkable achievement that underscores its tremendous potential and the confidence of leading international investors such as QVIDTVM and Bar?a Innovation Hub in its vision. At FCV Equity Group we are especially proud of this moment, having acted as lead investors in its previous funding round, closed during the challenging times of the COVID-19 pandemic ??. That round laid the foundation for the company’s resilience and growth, enabling it to navigate uncertainty and arise as the market reference it is now ?? . Congratulations to the entire team on this monumental accomplishment, as well as to the board members and shareholders that have made it possible with their unwavering dedication and support. ?? We are excited to continue supporting their mission and can't wait to see what the future holds!
?? ?? ?? Genomcore takes a giant leap forward by partnering with Bar?a Innovation Hub FC Barcelona and securing a €5 million funding round led by QVIDTVM. ???? This investment will supercharge the development of our cutting-edge Biomedical Information Management System (BIMS), revolutionizing how the healthcare industry integrates and manages complex multimodal health data. ?? With this funding, we’re set to expand our reach across Europe and advance our platform, driving breakthroughs in clinical genomics and R&D solutions that push the frontiers of precision health. -- ?? ?? ?? Genomcore alcanza nuevas alturas a través de un revolucionario acuerdo con el Bar?a Innovation Hub y el cierre de una ronda de financiación de 5 millones de euros liderada por QVIDTVM. ???? Esta inversión impulsará el desarrollo de nuestra innovadora plataforma Genomcore BIMS (Biomedical Information Management System), revolucionando cómo la industria sanitaria integra y gestiona datos complejos y multimodales de salud. ??Con esta financiación, expandiremos nuestro alcance por Europa y avanzaremos en el desarrollo de nuestra plataforma, impulsando avances en genómica clínica y soluciones de I+D que empujan los límites de la salud de precisión. #precisionmedicine #personalizedmedicine #precisionhealth #datadriven #complexdata #biomedicaldata #healthdata #healthcare #healthtech #pressrelease #partnership #funding #gamechanger #healthcarerevolution #innovation #digitaltransformation Oscar Flores Guri Miquel A. Bru Angelats Albert Mundet Joan Laporta Estruch Burak A.